Fungi, particularly yeasts, have become important opportunistic pathogens that can be resistant to antifungal agents or develop resistance. To address this problem, new molecules such as echinocandins, have been developed. Susceptibility to anidulafungin was studied in yeasts isolated previous to the introduction of this drug in Chile. One hundred strains of different yeast species isolated from invasive fungal infections during 2007 and 2008 were studied. Susceptibility testing of anidulafungin was performed by broth microdilution according to CLSI. All strains were susceptible to anidulafungin. MIC 50 and MIC 90 were 0.125 μg/mL and 1 μg/mL, respectively. Compared to other yeasts, C. parapsilosis showed a slight increase in the MICs for a...
This study furnishes deeper insights to previous works on anidulafungin, demonstrating the potent ac...
International audienceNew molecular identification techniques and the increased number of patients w...
The MICs of echinocandins against Candida isolates with fks mutations are higher than those for wild...
Anidulafungin is an antifungal drug belonging to the echinocandin class with a potent in vitro fungi...
Anidulafungin is a new echinocandin with potent in vitro activity against Aspergillus and Candida sp...
Anidulafungin is a new echinocandin with potent in vitro activity against Aspergillus and Candida sp...
The echinocandins are recommended as first-line therapy for Candida species infections, but drug res...
The echinocandins are recommended as first-line therapy for Candida species infections, but drug res...
Nosocomial yeast infections have increased significantly worldwide and especially in surgical and in...
The efficacy of anidulafungin, an echinocandin antifungal agent with potent anti-Candida activity, i...
Nosocomial yeast infections have increased significantly worldwide and especially in surgical and in...
of invasive candidiasis cases. Some less common Candida species have emerged as causes of nosocomial...
This study furnishes deeper insights to previous works on anidulafungin, demonstrating the potent ac...
New molecular identification techniques and the increased number of patients with various immune def...
International audienceNew molecular identification techniques and the increased number of patients w...
This study furnishes deeper insights to previous works on anidulafungin, demonstrating the potent ac...
International audienceNew molecular identification techniques and the increased number of patients w...
The MICs of echinocandins against Candida isolates with fks mutations are higher than those for wild...
Anidulafungin is an antifungal drug belonging to the echinocandin class with a potent in vitro fungi...
Anidulafungin is a new echinocandin with potent in vitro activity against Aspergillus and Candida sp...
Anidulafungin is a new echinocandin with potent in vitro activity against Aspergillus and Candida sp...
The echinocandins are recommended as first-line therapy for Candida species infections, but drug res...
The echinocandins are recommended as first-line therapy for Candida species infections, but drug res...
Nosocomial yeast infections have increased significantly worldwide and especially in surgical and in...
The efficacy of anidulafungin, an echinocandin antifungal agent with potent anti-Candida activity, i...
Nosocomial yeast infections have increased significantly worldwide and especially in surgical and in...
of invasive candidiasis cases. Some less common Candida species have emerged as causes of nosocomial...
This study furnishes deeper insights to previous works on anidulafungin, demonstrating the potent ac...
New molecular identification techniques and the increased number of patients with various immune def...
International audienceNew molecular identification techniques and the increased number of patients w...
This study furnishes deeper insights to previous works on anidulafungin, demonstrating the potent ac...
International audienceNew molecular identification techniques and the increased number of patients w...
The MICs of echinocandins against Candida isolates with fks mutations are higher than those for wild...